Cross-linking was pioneered in 1997 and eventually approved by the FDA in 2016. It is an office-based procedure that can slow, stop, and often reverse the effects of Keratoconus and post-LASIK ectasia. Patients may find that their corrected and uncorrected vision improves, and the risk of requiring corneal transplantation will decrease. As one of the original Avedro FDA investigation sites, our office performs cross-linking in a sterile, climate controlled operating suite using the latest technology.
Most major insurance companies cover cross-linking. For patients without adequate health policies we employ special programs and secure industry support to assure this vision preserving technology is available in all appropriate cases.
What to expect
At your initial consultation and evaluation, you can expect to meet with one of our doctors who will assess your corneal health from many dimensions. We evaluate any current contact lenses and glasses prescriptions you may have and perform our own measurements to asses the stability of your cornea. We utilize optical coherence tomography (OCT) and topography to gain an understanding of your corneal shape and dimensions to customize a treatment plan for you. Additionally, we answer all of your questions and explain the procedure before you leave.
If crosslinking is recommended for you, you can expect to have the procedure in the office with a familiar staff and environment. Post operative care can be managed in the office, or patients who are referred from other eye care providers can elect to do post operative care with their usual provider.
Contact our office for a cross-linking evaluation.